$DWTX
Dogwood Therapeutics, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Alpharetta, GA
DWTX chart
What traders are saying about $DWTX
Latest postsDogwood Therapeutics, Inc. news
- Sealbond Ltd Purchases 4,098,360 Shares of Dogwood Therapeutics at $1.22 Each
Kalkine Media ·
- Dogwood Therapeutics, Inc. Estimates – NASDAQ:DWTX
TradingView ·
- A 4.1M-share sale by Dogwood Therapeutics (DWTX) is expected to close by October 29.
Stock Titan ·
- Dogwood Announces $5 Million Private Placement with CK Life Sciences Int’l., (Holdings) Inc.
Yahoo Finance ·
- Dogwood to Participate in the 2026 Maxim Growth Summit
Yahoo Finance ·
- Dogwood Announces Completion of Enrollment in Ongoing Halneuron® Phase 2b Trial
Yahoo Finance ·
- Dogwood Therapeutics Nears Phase 2b Readout for Halneuron Neuropathic Pain Treatment
marketbeat.com ·
- Dogwood to Host Virtual KOL Event to Discuss Halneuron® for the Treatment of Chemotherapy Induced Neuropathic Pain on September 1, 2026
Yahoo Finance ·
- Dogwood Therapeutics Announces Second Quarter 2026 Financial Results
Yahoo Finance ·
- Dogwood Enrolls First 200 Patients in Ongoing Halneuron® Phase 2b Chemotherapy Induced Neuropathy Trial; Top-line Data Expected in Fall 2026
Yahoo Finance ·
- Dogwood Therapeutics Appoints Iain Dukes, Venture Partner at OrbiMed, as Chair of Scientific Advisory Board
Yahoo Finance ·
- Chemotherapy-Induced Peripheral Neuropathy Market to Witness Significant Growth at a CAGR of 14.2% During the Forecast Period (2026-2036) as Novel Therapies Enter Late-Stage Development | DelveInsight
Yahoo Finance ·
Dogwood Therapeutics, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Net income | -$34.3M | -$12.3M | -$5.3M | -$12.2M |
| Diluted EPS | $-7.13 | $-12.52 | $-7.05 | $-1.11 |
| Total assets (year end) | $90.2M | $94.3M | $4.2M | $8.4M |
| Cash and equivalents (year end) | $6.5M | $14.8M | $3.3M | $7.0M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Dogwood Therapeutics, Inc.
- Ticker
- DWTX (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Alpharetta, GA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1818844
- Former names
- Virios Therapeutics, Inc., Virios Therapeutics, LLC
Frequently asked questions
What exchange is Dogwood Therapeutics, Inc. listed on?
Dogwood Therapeutics, Inc. trades on the Nasdaq under the ticker symbol DWTX.
What industry is Dogwood Therapeutics, Inc. in?
Dogwood Therapeutics, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Dogwood Therapeutics, Inc. headquartered?
Dogwood Therapeutics, Inc.'s business address on file with the SEC is in Alpharetta, GA.
When does Dogwood Therapeutics, Inc.'s fiscal year end?
Dogwood Therapeutics, Inc.'s fiscal year ends on December 31.